1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. Russia >
  5. Horizon Capital Acquires Tinkoff Digital

M&A Deal Summary

Horizon Capital Acquires Tinkoff Digital

On October 31, 2012, private equity firm Horizon Capital acquired internet software and services company Tinkoff Digital

Acquisition Highlights
  • This is Horizon Capital’s 1st transaction in the Internet Software and Services sector.
  • This is Horizon Capital’s 1st transaction in Russia.

M&A Deal Summary
Date 2012-10-31
Target Tinkoff Digital
Sector Internet Software and Services
Buyer(s) Horizon Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

Tinkoff Digital

Moscow, Russia
Tinkoff Digital focuses on developing technologies and products for the online and mobile advertising markets.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Horizon Capital

Kyiv, Ukraine

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2006
PE ASSETS 1.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Horizon Capital is a private equity fund manager that targets investments in mid-cap companies with rapid growth and profit potential in Ukraine and Moldova. The firm seeks to invest between $5 million to $20 million per transaction. Horizon Capital uses investment proceeds primarily for expansion and buy-out opportunities in core industries that serve the emerging middle class. These industries include financial services, fast-moving consumer goods (FMCG), retail, manufacturing, and other select sectors. Horizon Capital was founded in 2006 and is based in Kyiv, Ukraine.

DEAL STATS #
Overall 11 of 25
Sector: Internet Software and Services M&A 1 of 2
Type: Buyout (LBO, MBO, MBI) M&A Deals 4 of 7
Country: Russia M&A 1 of 1
Year: 2012 M&A 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-12 Biofarma

Amoz, Ukraine

Biofarma is a pharmaceutical manufacturer focused on plasma protein products. The drugs are used in hematology, immunology, and intensive care medicine. The Company also manufactures biopharmaceutical products on the basis of genetically-produced recombinants used to improve the quality of life of patients with severe diseases. Biofarma is based in Amoz, Ukraine.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-05 Fidem Life

Kyiv, Ukraine

Fidem Life is a top 10 player in the life insurance market in Ukraine. The Company started operations in 2003. Since then it has successfully developed Ukraine's largest nation-wide agency network and considerably expanded its distribution capabilities in the broker, corporate and bancassurance channels over the past years. It is led by a talented and dedicated international management team.

Sell -
Mergr

Solution for

Product

Company

Legal